All In Biotech

Drug Trial Radar · NCT06007066

HSK16149 for Perioperative Analgesia in Orthopedic Surgery

A Multicenter, Randomized, Double-Blind, Placebo-controlled Phase II Study of The Efficacy And Safety of HSK16149 In The Treatment of Patients With Orthopedic Perioperative Analgesia

Last checked: Nov 20, 2026Latest source record: Aug 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 235 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

235

Actual

Start

Mar 8, 2023

Primary completion

Jun 12, 2023

Study completion Jul 5, 2023

Sponsor

Sponsor type
Industry
First posted
Aug 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will compare the effect and safety of HSK16149 with placebo on perioperative analgesia in orthopedic surgery, and explore the dosage of HSK16149 capsules for orthopedic analgesia during perioperative period.

Conditions

  • Post-operative Pain

Interventions

  • HSK16149 capsuleDrug

    Subjects will be given 40mg or 60mg of HSK16149 orally.

  • PlaceboDrug

    Subjects will be given HSK16149 placebo orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Morphine ConsumptionTime frame: Participants received PCA pump, an average of 24 hours after surgery

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • Sino-Japanese Friendship Hospital

    Beijing, China

  • Dongguan People's Hospital

    Dongguan, Guangdong, China

  • Foshan Fuxing Chancheng Hospital

    Foshan, Guangdong, China

  • The First Affiliated Hospital of Jinan University

    Guangzhou, Guangdong, China

  • Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, China

  • Beijing Jishuitan Hospital Guizhou Hospital

    Guiyang, Guizhou, China

  • Zunyi University Affiliated Hospital

    Zunyi, Guizhou, China

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China

  • People's Hospital of Wuhan University

    Wuhan, Hubei, China

  • Wuhan Central Hospital

    Wuhan, Hubei, China

  • Xiangya Third Hospital of Central South University

    Changsha, Hunan, China

  • The First Affiliated Hospital of South China University

    Hengyang, Hunan, China

  • Lianyungang First People's Hospital

    Lianyungang, Jiangsu, China

  • Nanjing First Hospital

    Nanjing, Jiangsu, China

  • Chengdu Second People's Hospital

    Chengdu, Sichuan, China

  • Chengdu Third People's Hospital

    Chengdu, Sichuan, China

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China

  • Guangyuan First People's Hospital

    Guangyuan, Sichuan, China

  • Mianyang Central Hospital

    Mianyang, Sichuan, China

  • Yibin Second People's Hospital

    Yibin, Sichuan, China

  • The First People's Hospital of Yunnan Province

    Kunming, Yunnan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.